In this episode, CM Life Science Business Manager, Nathan Rigby, speaks with Erez Naaman, Co-Founder & CTO at Scopio Labs. Prior to Scopio Labs, Erez was VP of Engineering & Business Development at OrCam, a leading Israeli high-tech start-up. He brings much of his insight from this experience to this discussion, as well as insight into the development of his current business, trends in AI and how he believes this affects the future of healthcare. Scopio Labs uses full-field digital cell morphology to automate the analysis of tens of thousands of cells at a time – far more than a ..read more

In this episode, Eleanor speaks with Delphine Galezowski, Director of Market Development in Europe for Adaptive Biotechnologies. We discuss European market expansion strategies within the diagnostics space, the differences between European market access and other global territories, and insights from her time leading teams at AstraZeneca. Whether you’re in the diagnostics industry, are intrigued by market access strategies, or are wondering how different organisations and regions differ within the market – then be sure to have a listen. In the following episodes my colleagues will be discus ..read more

In this season opener, we sit down with Krista Ewing, Senior Global Product Manager at Porex Corporation. As a renowned global leader in advanced porous solutions across various industries, including medical devices and writing instruments, it provides high-value solutions for product design challenges related to absorption, diffusion, filtration, and more. Nathan chats with Krista about the journey behind the development of TruFlow, the infamous lateral flow product that emerged in response to the challenges faced during the COVID-19 pandemic. The conversation highlights the critical issues ..read more

In part two of this three-part discussion, Adam and Dennis discuss the key barriers for entry for companies expanding into new territories and how to overcome these, whether you're a start-up or established company entering the market. Dennis brings insight from his broad and brilliant background in molecular oncology and precision medicine, with experience in all elements from research to pharma and commercial. Discussing the challenges and opportunities he's faced as the CEO of Predicine in Europe. This conversation comes in three parts. In part one, the pair discussed the importance of li ..read more

In this next episode of our 3-part series with the exciting POC diagnostics start-up, Nathan sits down with Bob Enk, Chairman & President, and Dr. Jesus Rodriguez Manzano, Chief Scientific Officer for an exclusive chat about the future of diagnostics with ProtonDx. Dr. Rodriguez Manzano has a strong interdisciplinary background in microbiology, molecular biology and bioengineering, and his research interest includes single-molecule technologies, machine learning applied to healthcare, and clinical diagnostics, with a particular interest in low- and middle-income countries. He is the ..read more

In this episode, we begin our 3-part series with the exciting POC diagnostics start-up, ProtonDx. ProtonDx is founded on a decade of research and development at Imperial College London. Its vision is to develop ultra‑rapid, extremely precise, molecular testing for everyone at the point‑of‑need. In 2022, the business received a CE mark for its cutting-edge Dragonfly product. Now the ProtonDx team are looking to commercialise this essential testing kit. Our conversations started with the co-founder and CEO, Professor Pantelis Georgiou. Pantelis holds the position of Professor of Biomedical Ele ..read more

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with Beth Cobb, Chief Operating Officer at NOWDiagnostics | NowDx. NOWDx is on a mission to develop rapid, accurate, affordable, and easy-to-administer over-the-counter and point-of-care diagnostic tests that return results in minutes. This innovative product is accompanied by a vision to create a world with vastly improved access to accurate healthcare information. Through providing access to quick and easy at home testing, patients and caregivers beco ..read more

In this episode of Diagnostics Digest, CM Life Science Business Manager Nathan Sharpe speaks with Kevin Fallon, CEO & Co-Founder of FlexMedical Solutions. Since 2016 FlexMedical has been on an exciting journey, jumping from strength to strength. From significant headcount growth to major investment in both equipment and facilities, the business has become one of the most trusted IVD manufacturers in the world in its short lifespan. Now, they're ready to make the next big move. Our team went to visit FlexMedical at their Scottish HQ, where Nathan caught up with Kevin to discuss the compan ..read more

In this episode of Diagnostics Digest, a CM Life Science series discussing trends and insights into the diagnostics market, I speak with David Wells, Chief Executive Officer of the Institute of Biomedical Science (IBMS). With over 21,000 members in 74 countries, IBMS is the leading professional body for scientists, support staff and students in the field of biomedical science. For over 100 years, it has been dedicated to the promotion, development and delivery of excellence in biomedical science within all aspects of healthcare, and to providing the highest standards of service to p ..read more

In the final part of this three-part episode, Dennis and Adam discuss new technologies to watch in the liquid biopsy market, as well as insights into innovation from behind the scenes at Predicine. Dennis touches on how to become a legendary company in your market, and what this means in liquid biopsy terms. A truly eye-opening discussion which anyone would be sure to gain something from. In parts one and two, we discussed the importance of liquid biopsy for the future oncology market as well as strategies for overcoming barriers when entering new markets. A huge thanks to Dennis for coming ..read more